Cargando…

Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS

A decade has passed since the publication on the comparison of the effect of adalimumab with data from a historic cohort on the progression of structural damage in the spine of patients with ankylosing spondylitis (AS). No effect could be observed, and currently, there is still no definite proof tha...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, Désirée, Landewé, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836371/
https://www.ncbi.nlm.nih.gov/pubmed/31694713
http://dx.doi.org/10.1186/s13075-019-2045-1